Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, United States.
Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland, United States.
Physiol Rev. 2024 Jul 1;104(3):1265-1333. doi: 10.1152/physrev.00017.2023. Epub 2023 Dec 28.
The complexity of cardiac electrophysiology, involving dynamic changes in numerous components across multiple spatial (from ion channel to organ) and temporal (from milliseconds to days) scales, makes an intuitive or empirical analysis of cardiac arrhythmogenesis challenging. Multiscale mechanistic computational models of cardiac electrophysiology provide precise control over individual parameters, and their reproducibility enables a thorough assessment of arrhythmia mechanisms. This review provides a comprehensive analysis of models of cardiac electrophysiology and arrhythmias, from the single cell to the organ level, and how they can be leveraged to better understand rhythm disorders in cardiac disease and to improve heart patient care. Key issues related to model development based on experimental data are discussed, and major families of human cardiomyocyte models and their applications are highlighted. An overview of organ-level computational modeling of cardiac electrophysiology and its clinical applications in personalized arrhythmia risk assessment and patient-specific therapy of atrial and ventricular arrhythmias is provided. The advancements presented here highlight how patient-specific computational models of the heart reconstructed from patient data have achieved success in predicting risk of sudden cardiac death and guiding optimal treatments of heart rhythm disorders. Finally, an outlook toward potential future advances, including the combination of mechanistic modeling and machine learning/artificial intelligence, is provided. As the field of cardiology is embarking on a journey toward precision medicine, personalized modeling of the heart is expected to become a key technology to guide pharmaceutical therapy, deployment of devices, and surgical interventions.
心脏电生理学的复杂性涉及多个空间(从离子通道到器官)和时间(从毫秒到天)尺度上众多成分的动态变化,使得对心脏心律失常发生机制的直观或经验分析具有挑战性。心脏电生理学的多尺度机械计算模型可以精确控制单个参数,其可重复性能够对心律失常机制进行全面评估。本综述从单细胞到器官水平,全面分析了心脏电生理学和心律失常模型,以及如何利用它们来更好地理解心脏疾病中的节律紊乱,并改善心脏病患者的护理。讨论了基于实验数据的模型开发的关键问题,并强调了主要的人类心肌细胞模型家族及其应用。概述了心脏电生理学的器官水平计算模型及其在个体化心律失常风险评估和心房、心室心律失常的患者特异性治疗中的临床应用。这里介绍的进展强调了如何从患者数据中重建的患者特异性心脏计算模型在预测心源性猝死风险和指导心脏节律紊乱的最佳治疗方面取得了成功。最后,展望了潜在的未来进展,包括机械建模与机器学习/人工智能的结合。随着心脏病学领域正在迈向精准医学,心脏的个性化建模有望成为指导药物治疗、器械部署和手术干预的关键技术。